(0.28%) 5 114.26 points
(0.39%) 38 389 points
(0.37%) 15 987 points
(-1.59%) $82.52
(4.99%) $2.02
(0.23%) $2 352.60
(0.21%) $27.59
(4.16%) $960.45
(-0.21%) $0.933
(-0.35%) $10.99
(-0.52%) $0.796
(1.69%) $93.42
0.00% INR 60.80
Live Chart Being Loaded With Signals
Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision...
Stats | |
---|---|
Dagens volum | 40 069.00 |
Gjennomsnittsvolum | 319 699 |
Markedsverdi | 1.26B |
EPS | INR0 ( 2024-02-15 ) |
Neste inntjeningsdato | ( INR0 ) 2024-05-21 |
Last Dividend | INR0.500 ( 2023-09-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 35.76 |
ATR14 | INR0.405 (0.66%) |
Volum Korrelasjon
Lotus Eye Hospital and Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Lotus Eye Hospital and Korrelasjon - Valuta/Råvare
Lotus Eye Hospital and Økonomi
Annual | 2022 |
Omsetning: | INR470.44M |
Bruttogevinst: | INR250.59M (53.27 %) |
EPS: | INR1.960 |
FY | 2022 |
Omsetning: | INR470.44M |
Bruttogevinst: | INR250.59M (53.27 %) |
EPS: | INR1.960 |
FY | 2022 |
Omsetning: | INR380.86M |
Bruttogevinst: | INR192.62M (50.58 %) |
EPS: | INR1.440 |
FY | 2021 |
Omsetning: | INR316.67M |
Bruttogevinst: | INR160.14M (50.57 %) |
EPS: | INR0.751 |
Financial Reports:
No articles found.
Lotus Eye Hospital and Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0.500 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0.500 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.500 | 2017-08-02 |
Last Dividend | INR0.500 | 2023-09-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | INR2.50 | -- |
Avg. Dividend % Per Year | 0.55% | -- |
Score | 1.54 | -- |
Div. Sustainability Score | 2.78 | |
Div.Growth Potential Score | 4.37 | |
Div. Directional Score | 3.57 | -- |
Year | Amount | Yield |
---|---|---|
2017 | INR0 | 0.00% |
2018 | INR0.500 | 1.72% |
2019 | INR0 | 0.00% |
2020 | INR0 | 0.00% |
2021 | INR0.500 | 1.45% |
2022 | INR0.500 | 0.95% |
2023 | INR0.500 | 0.62% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TCI.NS | Dividend Junior | 2023-07-25 | Semi-Annually | 23 | 0.70% | |
OBEROIRLTY.NS | Dividend Junior | 2023-06-21 | Sporadic | 14 | 0.19% | |
INFOBEAN.NS | Dividend Junior | 2023-07-21 | Annually | 7 | 0.37% | |
CONCOR.NS | Dividend Knight | 2023-09-18 | Semi-Annually | 23 | 0.89% | |
SCI.NS | Dividend Junior | 2023-09-01 | Sporadic | 22 | 0.25% | |
MALLCOM.NS | Dividend Junior | 2023-09-04 | Annually | 3 | 0.20% | |
GOKEX.NS | Dividend Junior | 2023-09-13 | Sporadic | 20 | 0.07% | |
AUTOAXLES.NS | Dividend Junior | 2023-07-27 | Annually | 22 | 0.72% | |
TRENT.NS | Dividend Junior | 2023-05-25 | Annually | 21 | 0.10% | |
PIDILITIND.NS | Dividend Junior | 2023-07-27 | Annually | 23 | 0.29% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0730 | 1.500 | 8.54 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0608 | 1.500 | -0.435 | -0.653 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 51.85 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.26 | 2.00 | 8.91 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.26 | 2.00 | 8.37 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.451 | 1.000 | 5.81 | 5.81 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0909 | 1.000 | -0.182 | -0.182 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.78 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 35.59 | 1.000 | 6.51 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0608 | 2.50 | -0.280 | -0.653 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.26 | 2.00 | 8.91 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.826 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.26 | 2.00 | 8.91 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.387 | 1.500 | -0.754 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.140 | 1.000 | 9.01 | 0 | [0.1 - 0.5] |
Total Score | 4.37 |
Lotus Eye Hospital and
Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision. The company also provides cataract and intraocular lenses, as well as operates an eye bank. In addition, it offers ophthalmic fellowship training courses in cornea, glaucoma, retina, and anterior segments, as well as DNB teaching and training services. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was incorporated in 1997 and is based in Coimbatore, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.